Academic Journal
Q3Transfusion Medicine
About Transfusion Medicine
Transfusion Medicine is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q3, with an SJR of 0.392 and H-index of 69.
Coverage: 1991-2026. Research categories: Hematology (Q3).
Verified field sources
- Editor(s): Dr David Roberts (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
- Journal Impact Factor: 1.3 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
Source-backed journal facts
Topics in published research
Blood groups and transfusion; Blood transfusion and management; Blood donation and transfusion practices; Hemoglobinopathies and Related Disorders; Trauma, Hemostasis, Coagulopathy, Resuscitation; Platelet Disorders and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,700.00 USD; 3,070.00 EUR; 2,500.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Red blood cell transfusion in sickle cell disease: From clinical necessity to immunological complexity
Mohamed Eltaib Elmobark, Mohamd Z. Sayed‐Ahmed, Mohammed Al‐Rasheed, Mohamed Marzok et al.
2026-10-01 · DOI: 10.1111/tme.70122Improved blood component quality and processing efficiency with a fully automated whole blood preparation system
Sinan Demircioğlu, Melda Cömert, Mehtap Yücel, İsmail Yaşar Avcı et al.
2026-09-29 · DOI: 10.1111/tme.70125Preoperative intravenous iron and red blood cell transfusion requirements in elderly intertrochanteric femoral fractures
Keong‐Hwan Kim, Gill Song, Yeon Sik Heo, Jinwon Jang et al.
2026-09-24 · DOI: 10.1111/tme.70121Developing key performance indicators using routinely collected healthcare data in obstetric patient blood management: A multi‐stage consensus study
Kate Fletcher, Hayley Evans, Asma Tameez‐Uddin, Gurman Kaur et al.
2026-09-11 · DOI: 10.1111/tme.70115Red blood cell‐directed immune responses in COVID ‐19: Mechanisms, clinical evidence and implications for transfusion medicine
Piotr Łojko, Alicja Tomasikiewicz
2026-09-06 · DOI: 10.1111/tme.70114Managing pregnancy in women with the Rh‐null phenotype: A structured narrative review of alloimmunisation, maternal–fetal outcomes and transfusion management
Ehsan Shahverdi, Mostafa Moghaddam
2026-09-04 · DOI: 10.1111/tme.70116Not all anti‐ CD38 antibodies are created equal: The epitope of felzartamab is partially DTT ‐resistant
Anja Zeretzke, Philipp Trummer, Cora P. Habicht, Clemens Schneeweiss et al.
2026-09-02 · DOI: 10.1111/tme.70112XLIII Annual Scientific Meeting of the British Blood Transfusion Society 15–17 September 2026 SEC Glasgow, UK
2026-09 · DOI: 10.1111/tme.70109Issue Information
2026-09 · DOI: 10.1111/tme.70110Author Index
2026-09 · DOI: 10.1111/tme.70111HIV risk reduction via confidential unit exclusion ( CUE ): A retrospective analysis of four high‐risk donor cases
Xinwei Wang, Ruru He, Baoren He, Xipeng Yan et al.
2026-09-01 · DOI: 10.1111/tme.70113From prediction to practice: Barriers to implementing artificial intelligence in blood inventory management and transfusion support
Paulina Kasperska‐Dębowska, Kornelia Kędziora‐Kornatowska
2026-08-04 · DOI: 10.1111/tme.70108Issue Information
2026-08 · DOI: 10.1111/tme.70060Seroprevalence of hepatitis B and C in asymptomatic blood donors in Saudi Arabia: A systematic review and meta‐analysis
Mohammad S. Alzahrani, Majed A. Algarni, Safa Boujemaa
2026-07-31 · DOI: 10.1111/tme.70107HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study
Suzete C. Ferreira, Anna S. Nishyia, Jerenice E. Ferreira, Claudia Di Lorenzo Oliveira et al.
2026-07-27 · DOI: 10.1111/tme.70106Research and application of machine learning models based on multimodal big data for precise transfusion management in acute myeloid leukaemia
Jiaheng Li, Xuezhe An, Zhongcui Jing, Ying Li et al.
2026-07-24 · DOI: 10.1111/tme.70105Tranexamic acid dosing in cardiac surgery: Preserving the evidence framework
Antoine Premachandra, Baptiste Monnier, Sylvain Diop
2026-07-22 · DOI: 10.1111/tme.70104Just one thing to reduce bleeding: Put tranexamic acid on the safe surgical checklist at your hospital
Ian Roberts, Katharine Ker
2026-07-19 · DOI: 10.1111/tme.70101Reviews
Community Reviews
Version History
October 2, 2026 at 9:42 pm
October 2, 2026